Laura Stewart, MD, FRCPC Clinical Associate Professor Division of Pediatric Endocrinology University of British Columbia

Similar documents
Precocious Puberty. Disclosures. No financial disclosures 2/28/2019

PedsCases Podcast Scripts

OBJECTIVES. Rebecca McEachern, MD. Puberty: Too early, Too Late or Just Right? Special Acknowledgements. Maryann Johnson M.Ed.

Puberty and Pubertal Disorders. Lisa Swartz Topor, MD, MMSc Pediatric Endocrinology July 2018

3 year old boy with puberty. Katie Stanley, MD August 1, 2013

Clinical Guideline ADRENARCHE MANAGEMENT OF CHILDREN PRESENTING WITH SIGNS OF EARLY ONSET PUBIC HAIR/BODY ODOUR/ACNE

Paul Hofman. Professor. Paediatrician Endocrinologist Liggins Institute, The University of Auckland, Starship Children Hospital, Auckland

PUBERTY. Preetha Krishnamoorthy. Division of Pediatric Endocrinology

2.0 Synopsis. Lupron Depot M Clinical Study Report R&D/09/093. (For National Authority Use Only) to Part of Dossier: Name of Study Drug:

5yo girl with vaginal bleeding. Matthew Wise, MD Med Peds Endo January 26, 2012

Hyperandrogenism. Dr Jack Biko. MB. BCh (Wits), MMED O & G (Pret), FCOG (SA), Dip Advanced Endoscopic Surgery(Kiel, Germany)

Precocious Puberty. Objectives After completing this article, readers should be able to:

Growth hormone therapy in a girl with Turner syndrome showing a large increase over the initially predicted ht of 4 5

Case. 24 year old female presented to your office complaining of excess hair growth on her face and abdomen. Questions?

Why is my body not changing? Conflicts of interest. Overview 11/9/2015. None

PERIPHERAL PRECOCIOUS PUBERTY SECONDARY TO MCCUNE-AL BRIGHT SYNDROME

Prescribing Guidelines Prescribing arrangement for the management of patients transferring from Secondary Care to Primary Care

Virilisation in siblings secondary to transdermal bioidentical testosterone exposure

Female Reproductive Endocrinology

Overview of Reproductive Endocrinology

2-year-old girl with premature thelarche. Endorama February 5, 2015 Carmen Mironovici, M.D.

SCHOOL OF MEDICINE AND HEALTH SCIENCES DIVISION OF BASIC MEDICAL SCIENCES DISCIPLINE OF BIOCHEMISTRY & MOLECULAR BIOLOGY

Precocious Puberty. Dr. Abdulmoein Eid Al-Agha Consultant, Pediatric Endocrinologist, King Abdul Aziz University Hospital, Jeddah, Saudi Arabia

Etiologies of Precocious Puberty: 15-Year Experience in a Tertiary Hospital in Southern Thailand

The University of Arizona Pediatric Residency Program. Primary Goals for Rotation. Endocrinology

2-Hypertrichosis:- Hypertrichosis is the

Dr. Nermine Salah El-Din Prof of Pediatrics

Polycystic Ovary Syndrome HEATHER BURKS, MD OU PHYSICIANS REPRODUCTIVE MEDICINE SEPTEMBER 21, 2018

12/27/2013. Kristen Cain, MD FACOG Reproductive Medicine Institute Sanford Health, Fargo ND

Provide preventive counseling to parents and patients with specific endocrine conditions about:

Precocious puberty: a clinical review

15) Presenting Problems in Reproductive Disease Dr. Taha

When testes make no testosterone: Identifying a rare cause of 46, XY female phenotype in adulthood

Children s Hospital & Research Center Oakland. Endocrinology

Polycystic Ovarian Syndrome (PCOS) LOGO

Dr Stella Milsom. Endocrinologist Fertility Associates Auckland. 12:30-12:40 When Puberty is PCO

Puberty and Pubertal Disorders Part 3: Delayed Puberty

Idiopathic central precocious puberty associated with an enlarged pituitary gland

Tower Hamlets GPs and Barts Health NHS Trust Shared Care Guidelines. TRIPTORELIN Central Precocious Puberty. Patient Name : Date of Birth: NHS No:

Case Questions. Polycystic Ovarian Syndrome: Treatment Goals and Options. Differential Diagnosis of Hyperandrogenic Anovulation

John Sutton, DO, FACOI, FACE, CCD. Carson Tahoe Endocrinology Carson City, NV KCOM Class of 1989

Follow-up Study of Adolescent Girls With a History of Premature Pubarche

Prof.Dr. Nabil Lymon Head of Internal Medicine Department

Reproductive Health and Pituitary Disease

3- & 12-Year-Old Sisters with Li-Fraumeni Syndrome KRISTEN DILLARD, M.D. ENDORAMA FEBRUARY 28, 2013

Stelios Mantis, MD DuPage Medical Group Pediatric Endocrinology

12/13/2017. Important references for PCOS. Polycystic Ovarian Syndrome (PCOS) for the Family Physician. 35 year old obese woman

Reproductive physiology

Management of Pediatric Fibrous Dysplasia/McCune-Albright Syndrome

Fibrous Dysplasia in Children. Professor Nick Shaw Birmingham Children s Hospital, UK

REI CASE(S) Laura L. Tatpati, MD Division of REI, Dept of OB/GYN KUSM - W

Reproductive FSH. Analyte Information

Polycystic Ovary Syndrome

Precocious Puberty (Complete, Partial)

Indications for Surgical Removal of Adrenal Glands

Supplemental Data: Detailed Characteristics of Patients with MKRN3. Patient 1 was born after an uneventful pregnancy. She presented in our

14 Girl with Cushing s Disease: An Update. Kristen Dillard, MD Endorama October 17, 2013

PTA/OTA 106 Unit 2 Lecture 4 Introduction to the Endocrine System

Audit of Adrenal Function Tests. Kate Davies Senior Lecturer in Children s Nursing London South Bank University London, UK

Medical management of Intersex disorders. Dr. Abdulmoein Al-Agha, Ass. Professor & Consultant Pediatric Endocrinologist KAAUH, Jeddah

Reproductive DHEA-S Analyte Information

Disclosure. Session Objectives. I have no actual or potential conflict of interest in relation to this program/presentation.

ROTATION SUMMARY ENDOCRINOLOGY

ROLE OF HORMONAL ASSAY IN DIAGNOSING PCOD DR GAANA SREENIVAS (JSS,MYSURU)

By Jennifer F. Teskey, MD; Heather J. Dean, MD, FRCPC; and Elizabeth AC Sellers, MSc, MD, FRCPC. amenorrhea. Following menarche 3. How to treat PCOS.

Adrenal incidentaloma guideline for Northern Endocrine Network

Endocrinological Outcome Among Treated Craniopharyngioma Patients

Endocrine part one. Presented by Dr. Mohammad Saadeh The requirements for the Clinical Chemistry Philadelphia University Faculty of pharmacy

Isosexual precocity: current concepts and recent advances

16 YEAR-OLD OBESE FEMALE WITH OLIGOMENORRHEA

PRENATAL TREATMENT AND FERTILITY OF FEMALE PATIENTS WITH CONGENITAL ADRENAL HYPERPLASIA

Prof. Dr. Michael Zitzmann Internal Medicine Endocrinology, Diabetology, Andrology University of Muenster, Germany

SEX STERIOD HORMONES I: An Overview. University of PNG School of Medicine & Health Sciences Division of Basic Medical Sciences PBL MBBS III VJ Temple

Very premature pubarche in girls is not a pubertal variant

PITUITARY: JUST THE BASICS PART 2 THE PATIENT

lactotrophs 120 min- FSH 60 min- LH Hypothalamus GnRH pituitary Estradiol +/- Progesterone _ FSH L H Ovary Uterus Ovulation Antral follicle >2mm

When menarche does not occur a pediatric view

Polycystic Ovarian Syndrome. Heidi Hallonquist, MD Concord Hospital Concord Obstetrics and Gynecology

ComprehensivePLUS Hormone Profile with hgh

A Case of Atypical McCune-Albright Syndrome with Vaginal Bleeding

Endocrine Features of Fibrous Dysplasia/McCune-Albright Syndrome

IN SUMMARY HST 071 NORMAL & ABNORMAL SEXUAL DIFFERENTIATION Fetal Sex Differentiation Postnatal Diagnosis and Management of Intersex Abnormalities

Role of surgical resection in the treatment of hypothalamic hamartomas causing precocious puberty Report of six cases

MRCPUK SEND Exam. Volume: 200 Questions

Primary Neonatal and paediatric Consultant Dr M Gnanabalan Operating Paediatric Surgeon Dr P Balamourugane Paediatric Pathologist Dr Seetha lakshmi

PREP Pediatric Endocrinology General session. Srinath Sanda, M.D. UC San Francisco

GONADAL FUNCTION: An Overview

DEFINITION: Masculinization of external genitalia in patients with normal 46XX karyotype.

POLYCYSTIC OVARIAN SYNDROME WHERE WE ARE AT IN 2018

Growth and Puberty: A clinical approach. Dr Esko Wiltshire

A single sample GnRHa stimulation test in the diagnosis of precocious puberty

What we will cover. Evaluation of the Child with Suspected Pituitary Disease. ituitary

Paul Hofman. Professor. Paediatrician Endocrinologist Liggins Institute, The University of Auckland, Starship Children Hospital, Auckland

From the editors desk

CUSHING S SYNDROME THE FACTS YOU NEED TO KNOW

More than meets the eye

Neuroendocrine Disorders in Women

Pituitary Gland Disorders

Index. urologic.theclinics.com. Note: Page numbers of article titles are in boldface type.

Mineralocorticoids: aldosterone Angiotensin II/renin regulation by sympathetic tone; High potassium will stimulate and ACTH Increase in aldosterone

Transcription:

Precocious Puberty Laura Stewart, MD, FRCPC Clinical Associate Professor Division of Pediatric Endocrinology University of British Columbia

Faculty Disclosure Faculty: Laura Stewart No relationships with commercial interests

Objectives To review causes of pubertal changes that present earlier than normal An approach to investigation and management of children with early puberty To review cases of children presenting with early pubertal changes Determine which presentations of early pubertal development require prompt investigation and management

Definition of Precocious Puberty Puberty with an onset prior to age 7 in girls and age 9 in boys Menarche prior to 9.5 years of age Complete precocious puberty refers to activation of the hypothalamic-pituitary gonadal axis Incomplete puberty is either isolated breast development or pubic hair development

Initiation Of Puberty Leptin levels increase as puberty nears and it is needed for the initiation of puberty As the adiposity increases, so do leptin levels This explains the fact that overweight girls enter puberty earlier and may also explain the secular trend for earlier puberty

Benign Variants of Early Pubertal Development Premature Thelarche Premature Adrenarche Constitutionally Early Puberty

Central Precocious Puberty Early activation of the hypothalamic-pituitarygonadal axis prior to age 6 in girls is often associated with rapid pubertal progression Those with an onset after age 6 in girls and after 8 in boys often have a gradual pubertal progression and preserved adult height The cause is idiopathic in 95% of girls Boys often have an identifiable cause

Central Precocious Puberty Neurological disorders such as hydrocephalus and epilepsy can be associated with CPP Hypothalamic hamartomas often are associated with puberty that begins at a very young age Other tumors (astrocytomas, CNS germ cell tumors, ependymomas) may cause CPP The inhibitory neurons are damaged by cranial irradiation

Central Precocious Puberty Activation of the hypothalamic-pituitarygonadal axis can occur after conditions resulting in chronic sex steroid exposure are treated This seen in children with CAH, McCune- Albright syndrome, Familial Gonadotropin- Independent Sexual Precocity

Incomplete Puberty: Thelarche Benign premature thelarche Functional Ovarian cysts McCune Albright syndrome (activating mutation of the α- subunit of the G protein) Granulosa cell ovarian tumours Exogenous estrogen exposure Severe primary hypothyroidism It may be the first sign of CPP

Isolated Pubarche In Girls Benign premature adrenarche Congenital adrenal hyperplasia Adrenal adenomas or carcinomas Masculinizing ovarian tumors (leydig-sertoli cell tumors) Exposure to exogenous androgens

Males With Peripheral Androgen Production Benign premature adrenarche Congenital adrenal hyperplasia Androgen-secreting adrenal tumours Testicular tumours (leydig-cell, interstitial cell tumours) HCG-secreting tumours

Males With Peripheral Androgen Production Familial gonadotropin-independent sexual precocity (AD sex-limited disorder secondary to a mutation of the LH receptor @ the G protein-binding domain) McCune-Albright syndrome (rare) Exogenous androgen exposure

Approach To Children Presenting With Early pubertal Changes Obtain a history of the onset and progression of puberty Exposure to exogenous sex steroids Symptoms of increased intracranial pressure & associated neurological problems Symptoms of adrenal insufficiency Tanner staging (including testicular volume in boys)

Precocious Puberty: Investigations In children with minimal pubertal changes or those who are presenting within the early normal timing of puberty, clinical follow-up may be all that is needed LH, FSH & sex steroid levels GnRH stimulation test may be needed Bone age In documented gonadotropin-dependent puberty, a cranial MRI is needed

Isolated Pubarche: Investigations Check cortisol and 17-hydroxyprogesterone levels between 0730 and 0800 hours An ACTH stimulation test may be needed DHEAS, Testosterone In boys, an HCG level is useful If there is gonadotropin-independent puberty and CAH is ruled out, an adrenal or testicular ultrasound may be needed

Isolated Thelarche: Investigations In girls who are in the infant to 2 year-old range and have mild thelarche, clinical followup is all that is needed Gonadotropin, estradiol levels, +/- GnRH test Bone age TSH If there is gonadotropin-independent puberty, a pelvic ultrasound may be needed

Central Precocious Puberty: Treatment Medical intervention is not needed in children with slowly progressive puberty or those with onset later than 6 years in girls or 8 in boys These families need reassurance They need information explaining the pubertal process and ways to help their child deal with the changes There are good resources for children and parents that explain pubertal changes

Central Precocious Puberty: Treatment GnRH agonists are used in children with rapidly-progressive CPP For girls who start puberty prior to 6 & boys beginning prior to age 7-8, there is evidence that GnRH agonists improve adult height as well as suppression of puberty For those with peripheral puberty, the underlying condition needs to be treated

Case: Jada Jada is a 28 month old girl who has bilateral breast development He mother feels that the tissue has been there for 4-5 months and it has not progressed significantly There is no pubic or axillary hair development There is no vaginal bleeding or discharge She is otherwise well

Case: Jada On examination, her height is 90.5 cm (50%), weight 13.3 kg (75%) Her general examination is normal She is Tanner 2 for breast development and stage 1 for pubic hair development

Case: Jada LH <0.2 IU/L, FSH 4.2 IU/L, estradiol 52 pmol/l The bone age was 2 10/12 years

Case: Jada She has benign premature thelarche This condition is associated with delayed suppression of the hypothalamic-pituitary gonadal axis There is often a history of waxing and waning of the breast size Usually clinical observation is all that is required

Case: Tina Tina is a 29 month old girl who was referred because of early pubertal changes She was noted to have breast development at 24 months of age She was noted to have blood in her diaper at 26 months of age At 28 months, she had 3 days of vaginal bleeding

Case: Tina On physical examination, her height is 108 cm (>98%) and weight 18.7 kg (>98%) She has a normal general examination She is Tanner stage 3 for breast development and 1 for pubic hair development

Case: Tina The bone age was 5 9/12 years. GnRH Test Time LH (U/L) FSH (U/L) Estradiol 0 2.8 2.4 160 20 32.0 9.2 30 30.0 9.8 40 9.0 10.2

Case Tina She has central precocious puberty Her MRI scan shows a hypothalamic hamartoma She is managed with Lupron Depot The breast tissue regresses She has no further menses

Case: Joan Joan was referred because of early pubertal development At 4 4/12 years she had breast development followed by brown vaginal discharge and then menses, lasting for 2 days It progressed rapidly over 2 weeks The breast development regressed

Case: Joan She had a second episode 3 months later The breast development progressed rapidly Menses occurred 1 week later and lasted for 5 days Her height is 113 cm (>95%) and weight is 25.4kg (>95%)

Case: Joan Her general physical examination was normal She is Tanner 3 breast, Tanner 1 pubic hair development She has 2 café au lait spots. One was 0.5 cm in diameter and was located on her right forearm and the other was 0.6 cm and was on her abdomen

Case: Joan The bone age was 6 10/12 years GnRH Stimulation Test Time LH (U/L) FSH (U/L) Estradiol 0 <0.1 <0.1 198 20 <0.1 <0.1 30 <0.1 <0.1 40 <0.1 <0.1

Case: Joan A pelvic ultrasound shows multiple large ovarian cysts on both ovaries A skeletal survey shows multiple areas of polyostotic fibrous dysplasia

Ovarian Cysts The estrogen levels climb rapidly & are often high There often is dark pigment around the areola and labia minora When the cyst resolves, menses can occur Large cysts can lead to ovarian torsion Girls with recurrent cysts may have MAS

McCune- Albright Syndrome Cafe Au Lait spots Fibrous dysplasia of bone Peripheral precocious puberty It can be associated with other endocrinopathies

Case: Joan She has McCune Albright Syndrome Aromatase inhibitors are somewhat effective She will need ongoing monitoring for pathological fractures

Hayden He is a 4 10/12 year old boy who was referred for pubic hair development and acne He has never been hospitalized He is on no medication There has been no growth spurt There is no family history of early puberty, virilization or unexplained deaths

Case: Hayden His height is 116.2cm (97%ile), weight 24 kg (97%ile) BP 93/55 His general examination is normal He is Tanner 3 for pubic hair development The testicular volume is 2 ml

Case: Hayden The bone age is 7 10/12 years Sodium 138 mmol/l, potassium 4.1 mmol/l His cortisol is 265 nmol/l @ 0750 h The 17-hydroxyprogesterone is 16.9 nmol/l ACTH Stimulation Test Time Cortisol 17-OHP 0 238 13.7 60 298 378

Case: Hayden He has simple virilizing 21-hydroxylase deficiency He is treated with hydrocortisone replacement

Case: Alison Alison is 7 years of age and has a 6 month history of pubic and axillary hair development She may have some breast development She has not had menarche There is no access to estrogen or androgencontaining medication She has been overweight for the last 4 years Her height remains on the 75%ile

Case: Alison Her height is 125 cm (75%ile) and weight 42 kg (>97%ile), BMI 26.9 kg/m2 (>97%ile) Her general examination is normal She has acanthosis nigricans She is Tanner 1 for breast development but has a significant amount of adipose tissue in the breast area She is Tanner 2 for pubic hair

Case: Alison Her bone age is 8 10/12 years DHEAS 3.9 umol/l Testosterone 0.4 nmol/l Cortisol 498 nmol/l @0755 h 17-OHP 4.6 nmol/l @0755 h Fasting glucose 5.3 mmol/l Fasting Insulin 256 pmol/l

Case: Alison She has benign premature adrenarche The DHEAS is appropriate for her pubic hair stage She does not have CAH Central puberty usually begins at a normal time This condition is often the first sign of the metabolic syndrome

Case: Sarah Sarah is 7 years, one month of age and presents with a 10 month history of rapid weight gain She also had pubic and axillary hair development that has progressed She has hirsutism which has been treated with laser therapy for 6 months There is no voice change

Case: Sarah There is breast development but she has not had menarche She continues to grow normally She has no symptoms suggestive of adrenal insufficiency She is on no medications. Her past history is unremarkable

Case: Sarah Her height is 126.2 cm, weight 33.5 kg, BP 135/80, heart rate 98 She has no dysmorphic features There is generalized obesity and the appearance of increased musculature Her general examination was normal She had severe acne

Case: Sarah There was moderate hair growth involving the side-burn area, upper lip, chin, neck, chest and abdomen She is Tanner 5 for pubic hair development and Tanner 2 for breast development She has mild clitoromegaly

Case: Sarah Sodium 140 mmol/l, potassium 4.2 mmol/l Glucose 8.4 mmol/l TSH 1.2 mu/l, free T4 12.8 pmol/l DHEAS 22.4 umol/l Free testosterone 8.9 pmol/l ACTH < 1.0 pmol/l, cortisol 890 nmol/l, 17-OHP 8.9 nmol/l @ 1730 h LH 1.2 U/L, FSH 1.2 U/L, estradiol 51 pmol/l

Case: Sarah A 24 hour urine collection showed a cortisol of 1670 nmol/l, creatinine 11.8 mmol/d The morning cortisol after 1 mg of dexamethasone was 780 nmol/l The abdominal ultrasound showed a right adrenal mass

Case: Sarah Sarah has a virilising adrenal tumour These tumours are often malignant She needs imaging to rule out metastases The curative treatment is surgical excision of the adrenal gland that harbors the tumor

Adrenocortical Tumors These tumors can present in young children They may present with features of Cushing syndrome but often present with virilization, especially if malignant The progression of the virilization is often rapid There may be associated breast development in some children secondary to aromatase action on the androgens

Features of Pathological Causes of Early Puberty Young age of pubertal onset Rapidly progressive puberty Evidence of virilization such as clitoromegaly or significant hirsutism Significant growth spurt and/or advanced bone age Associated neurological abnormalities